The De–Long test indicated that Lp‐PLA2 combined with Lp(a) had better predictive efficacy for the long‐term poor prognosis of patients with AIS, which was better than Lp‐PLA2 (AUC 0.794 [95% CI 0.753–0.836] vs. AUC 0.716 [95% CI 0.659–0.773]; p = 0.001) or Lp(a) (AUC 0.794 [95% CI 0.753–0.836] vs. AUC 0.730 [95% CI 0.678–0.783]; p = 0.015) (Table 6). Here, LPA is linked to androgen insensitivity syndrome.